(Q81367445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Obesity, fatty acid synthase, and cancer: serendipity or forgotten causal linkage? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ramon Colomer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Ruth Lupu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

9 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

293-295

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Synthesis and antitumor activity of an inhibitor of fatty acid synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Block the FAS, lose the fat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Hepatic and whole-body fat synthesis in humans during carbohydrate overfeeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Insulin-like growth factors and neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Deregulated degradation of the cdk inhibitor p27 and malignant transformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

A novel missense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percentage of body fat and substrate oxidation rates in nondiabetic Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.10.007

10.1016/J.YMGME.2004.10.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15694180%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference